Home > Products
 


R&D
2023-05-24 visits:4884


1. Super-large-capacity humanized IgM antibody library with fully independent intellectual property


2.? Bispecific antibody platform with independent intellectual property


3. Progressive animal model for indication screening was constructed independently



Hotline:+86-0571-87314597
R&D Center U.S.A
ADD:5107 Pegasus Court, Suite L Frederick, MD 21704
R&D Center CHINA :
ADD: 2008 Huachuang Edifice, Jianye RD No.511, Binjiang, Hangzhou
ICP NO. 18020885-1 | 33010802013098 Copyright2018 Zhejiang Shimai Pharmaceutical Co.,Ltd DESIGNBY:5ISJ.COM